NCI has launched a second-generation precision medicine clinical trial called Myeloid Malignancies Molecular Analysis for Therapy Choice, or myeloMATCH, a trial focused on acute myeloid leukemia and myelodysplastic syndromes.
An estimated 5,200 of HHS employees have been fired during the course of this week. Since the firings are ongoing, no final tally of their extent exists. At this writing, approximately 1,200 of the fired HHS employees were working at NIH, about 700 at FDA, and 750 at CDC.
